How Much Does Crestor (Rosuvastatin) Cost in Massachusetts in 2026?

Brand vs. Generic Rosuvastatin Pricing in Massachusetts

The price gap between brand-name Crestor and its generic equivalent is enormous. AstraZeneca's list price for Crestor sits near $290 per month in 2026, while generic rosuvastatin calcium tablets average roughly $15 per month across Massachusetts retail pharmacies. That is a 95% reduction.

Why the Generic Is So Cheap

Rosuvastatin lost patent exclusivity in 2016, and multiple manufacturers now produce the generic tablet. Competition among generic makers (including Teva, Aurobindo, and Lupin) has driven the cash price well below $20 per month at most chain pharmacies in Boston, Worcester, Springfield, and across the state. At some discount pharmacies and with coupon programs, 30-day supplies of rosuvastatin 10 mg or 20 mg can drop below $10.

When Brand Crestor Might Still Show Up

Some patients receive brand-name Crestor because their insurance formulary auto-substitutes to a specific NDC, or because a prescriber writes "dispense as written" for clinical reasons such as excipient sensitivities. If your pharmacy fills brand Crestor without a generic substitution, expect to pay significantly more out of pocket. Massachusetts law permits pharmacists to substitute generics unless the prescriber explicitly prohibits it under M.G.L. C. 112 §12D.

Retail Price Variation Across MA

Prices vary by pharmacy. A 2024 analysis of statin pricing found that cash-pay costs for the same generic drug can differ by 300% or more between pharmacies in the same zip code [1]. Calling two or three pharmacies before filling a prescription, or using a price-comparison tool, can save $5 to $15 per month on rosuvastatin.

Massachusetts Medicaid (MassHealth) Coverage for Rosuvastatin

MassHealth covers rosuvastatin, but the program requires prior authorization (PA) before approving coverage. This means your prescriber must submit clinical documentation showing that rosuvastatin is medically necessary for your diagnosis.

How Prior Authorization Works

PA for statins under MassHealth typically requires documentation of the patient's LDL cholesterol level, cardiovascular risk factors (diabetes, hypertension, smoking history), and any prior statin trials. The MassHealth Drug List classifies rosuvastatin as a preferred agent within the statin class for most plan types, but PA remains a gate. Approval turnaround is usually 24 to 72 hours for standard requests.

What If PA Is Denied?

If MassHealth denies the PA, your prescriber can file an appeal or switch to a formulary-preferred statin that does not require PA (atorvastatin is often the first-line preferred option on state Medicaid formularies). The 2018 AHA/ACC Cholesterol Guideline recommends high-intensity statin therapy for patients with clinical ASCVD, and rosuvastatin 20 to 40 mg is one of only two high-intensity options (the other being atorvastatin 40 to 80 mg) [2].

Copay Amounts on MassHealth

For most MassHealth Standard members, generic prescription copays are $1 to $3.65 per fill. Brand-name copays are higher. If your pharmacy dispenses generic rosuvastatin under MassHealth, expect minimal out-of-pocket cost after PA approval.

Insurance Coverage for Crestor and Rosuvastatin in Massachusetts

Most commercial insurance plans in Massachusetts cover generic rosuvastatin on their preferred formulary tier. Brand Crestor, if covered at all, sits on a higher (non-preferred or specialty) tier with larger copays.

Major Carriers and Formulary Placement

Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan, and Fallon Health all list generic rosuvastatin as a Tier 1 or Tier 2 drug. Typical copays for Tier 1 generics range from $0 to $15 per 30-day supply. Tier 2 copays range from $15 to $35. Brand Crestor, when listed, usually falls on Tier 3 with copays of $40 to $75 or higher.

Medicare Part D in Massachusetts

Medicare Part D plans in Massachusetts universally cover generic rosuvastatin. During the Initial Coverage Phase, most Part D plans charge $1 to $10 for preferred generics. Under the Inflation Reduction Act provisions taking effect through 2025 and 2026, Medicare beneficiaries now benefit from a $2,000 annual out-of-pocket cap, which makes even higher-cost medications more predictable [3].

Employer-Sponsored Plans

Large employer plans in Massachusetts (Partners HealthCare/Mass General Brigham employee plans, state employee GIC plans, university plans) consistently place generic rosuvastatin on the lowest copay tier. The GIC, which covers state employees, retirees, and their dependents, lists rosuvastatin with a $5 generic copay at retail pharmacies.

Compounded Rosuvastatin in Massachusetts: Legality and Access

Compounded rosuvastatin is legal in Massachusetts when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. This route is sometimes used for patients who need a custom dose, liquid formulation, or a version free of specific inactive ingredients (dyes, lactose, or other excipients).

503A vs. 503B Pharmacies

A 503A pharmacy compounds individual prescriptions for identified patients. A 503B outsourcing facility compounds larger batches without patient-specific prescriptions and is registered with the FDA. Both are legal in Massachusetts. The Massachusetts Board of Registration in Pharmacy oversees state-level compounding regulations.

Cost of Compounded Rosuvastatin

Compounded rosuvastatin from a 503A pharmacy in Massachusetts may cost between $0 and $30 per month depending on the pharmacy, dose, and formulation. Some compounding pharmacies offer statin formulations at very low cost as a standard offering. Insurance coverage for compounded medications varies. Most commercial plans do not cover compounded drugs unless the prescriber documents medical necessity for the compounded version over the commercially available generic.

When Compounding Makes Clinical Sense

Compounding is appropriate when a patient has a documented allergy or intolerance to an inactive ingredient in all available commercial rosuvastatin products, or when a patient cannot swallow tablets and needs a liquid suspension. The FDA's guidance on compounding specifies that compounded drugs should not be copies of commercially available products unless there is a clinical reason [4].

Telehealth Prescribing of Rosuvastatin in Massachusetts

Massachusetts permits telehealth prescribing of rosuvastatin. The state's telehealth parity law (updated through pandemic-era extensions and made permanent in 2021) allows clinicians to prescribe non-controlled medications, including statins, after a synchronous video or audio visit.

How Telehealth Statin Prescribing Works

A licensed Massachusetts prescriber conducts a clinical evaluation via video or phone. If the patient's lipid panel, cardiovascular risk profile, and medical history support statin therapy, the prescriber sends an electronic prescription to the patient's chosen pharmacy. No in-person visit is required for the initial prescription or refills.

Lab Work Requirements

Prescribers typically require a recent lipid panel (within the past 12 months) and a hepatic function panel before initiating rosuvastatin. The 2018 AHA/ACC guideline recommends checking a fasting lipid profile and ALT/AST before starting statin therapy and repeating the lipid panel 4 to 12 weeks after initiation to assess response [2]. Quest Diagnostics, Labcorp, and many urgent care clinics across Massachusetts offer walk-in lab draws that can be ordered remotely by a telehealth provider.

HealthRX Telehealth Access

HealthRX offers telehealth consultations for cardiovascular risk management, including statin prescriptions, for Massachusetts residents. Board-certified clinicians review your labs, assess your risk using validated tools like the Pooled Cohort Equations, and prescribe rosuvastatin if clinically appropriate.

Clinical Evidence: Why Rosuvastatin Specifically?

Rosuvastatin is one of the two most potent statins available. The choice between rosuvastatin and atorvastatin often comes down to LDL-lowering potency, side-effect profile, and insurance formulary position.

The JUPITER Trial

The landmark JUPITER trial (N=17,802) randomized patients with LDL cholesterol <130 mg/dL but elevated high-sensitivity C-reactive protein (hsCRP ≥ 2.0 mg/L) to rosuvastatin 20 mg daily versus placebo. At a median follow-up of 1.9 years, rosuvastatin reduced the primary composite endpoint of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or cardiovascular death by 44% (HR 0.56, 95% CI 0.46 to 0.69, P<0.00001) [1]. The trial was stopped early because the benefit was so clear.

LDL Reduction by Dose

Rosuvastatin's LDL-lowering capacity by dose, based on FDA labeling data [5]:

| Dose | Average LDL Reduction | |------|----------------------| | 5 mg | 38% | | 10 mg | 43 to 46% | | 20 mg | 48 to 52% | | 40 mg | 53 to 55% |

At 20 mg, rosuvastatin produces LDL reductions comparable to atorvastatin 80 mg, the maximum dose of the other high-intensity statin. At rosuvastatin 40 mg, LDL reductions can exceed 55%, a threshold difficult to reach with any other single oral statin.

Safety Profile

The most common side effects of rosuvastatin are myalgia (muscle pain, reported in 2 to 5% of patients), headache, and gastrointestinal discomfort. Serious adverse effects including rhabdomyolysis are rare. The FDA label recommends monitoring for signs of myopathy, particularly at the 40 mg dose and in patients of Asian descent, who may have higher rosuvastatin plasma levels due to pharmacogenomic differences in ABCG2 and SLCO1B1 transporters [5]. A 2022 meta-analysis of statin-associated muscle symptoms found that nocebo effects accounted for a significant proportion of reported myalgia in clinical trials [6].

Discount Programs and Savings Strategies

Several options exist for Massachusetts residents looking to minimize rosuvastatin costs beyond standard insurance.

Manufacturer and Third-Party Savings Cards

AstraZeneca's savings program for brand Crestor is largely irrelevant for patients who can take the generic, but some third-party discount cards (GoodRx, RxSaver, SingleCare) offer coupons that bring generic rosuvastatin below $10 per month at CVS, Walgreens, and independent pharmacies in Massachusetts. These cards work for uninsured or underinsured patients and sometimes beat insurance copays.

Mark Cuban Cost Plus Drugs

Cost Plus Drugs sells generic rosuvastatin at a transparent markup over manufacturing cost. Prices typically range from $3 to $6 for a 30-day supply, plus shipping. This option works for any Massachusetts resident, regardless of insurance status.

Patient Assistance Programs

AstraZeneca's AZ&Me program provides brand Crestor at no cost to qualifying patients who are uninsured and meet income thresholds (typically at or below 300% of the federal poverty level). Application requires proof of income and a valid prescription. For a drug that costs $15 per month in generic form, patient assistance programs are rarely needed, but they exist for the rare patient who requires brand Crestor.

90-Day Fills and Mail Order

Most Massachusetts insurance plans, including MassHealth managed care organizations, offer 90-day fills at lower per-unit cost. Mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) often charge two copays for a 90-day supply rather than three, saving one copay every quarter.

Massachusetts-Specific Regulatory Considerations

Massachusetts has several state-level policies that affect statin access and cost.

Generic Substitution Law

Massachusetts requires pharmacists to dispense the generic equivalent of a prescribed brand-name drug unless the prescriber writes "brand medically necessary" on the prescription. This law keeps most rosuvastatin prescriptions at the generic price point.

Step Therapy Protections

Massachusetts enacted step therapy reform legislation requiring insurers to grant exceptions to step therapy protocols when a patient has already tried and failed the required first-line drug, when the first-line drug is contraindicated, or when the prescriber provides clinical justification. This is relevant if your plan requires trying atorvastatin before covering rosuvastatin [7].

Telehealth Prescribing Rules

The Massachusetts Board of Registration in Medicine permits prescribing of non-controlled medications via telehealth without requiring an in-person visit. Rosuvastatin is not a controlled substance, so there are no DEA scheduling barriers to telehealth prescribing in the state.